A Single-Arm Study to Assess the Safety of Transplantation With Human Placental-Derived Stem-Cells Combined With Unrelated and Related Cord Blood in Subjects With Certain Malignant Hematologic Diseases and Non-Malignant Disorders

Trial Profile

A Single-Arm Study to Assess the Safety of Transplantation With Human Placental-Derived Stem-Cells Combined With Unrelated and Related Cord Blood in Subjects With Certain Malignant Hematologic Diseases and Non-Malignant Disorders

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 27 Dec 2017

At a glance

  • Drugs PSC 100 (Primary)
  • Indications Acute myeloid leukaemia; Adrenoleucodystrophy; Anaemia; Gaucher's disease; Globoid cell leukodystrophy; Metachromatic leukodystrophy; Mucopolysaccharidosis I; Mucopolysaccharidosis VI; Myelodysplastic syndromes; Neuronal ceroid lipofuscinosis; Niemann-Pick diseases; Precursor cell lymphoblastic leukaemia-lymphoma; Thrombocytopenia; Wolman disease
  • Focus Adverse reactions
  • Most Recent Events

    • 20 Dec 2017 Status changed from recruiting to active, no longer recruiting.
    • 28 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top